# Subclinical Primary Aldosteronism in Diabetes At-Risk for Kidney Disease

> **NCT06190158** · EARLY_PHASE1 · RECRUITING · sponsor: **Brigham and Women's Hospital** · enrollment: 125 (estimated)

## Conditions studied

- Type 2 Diabetes
- Chronic Kidney Diseases

## Interventions

- **DIAGNOSTIC_TEST:** Oral sodium suppression test
- **DIAGNOSTIC_TEST:** Saline suppression test
- **DIAGNOSTIC_TEST:** Captopril suppression test
- **DIAGNOSTIC_TEST:** Dexamethasone suppression test
- **DIAGNOSTIC_TEST:** Cosyntropin stimulation test

## Key facts

- **NCT ID:** NCT06190158
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-15
- **Primary completion:** 2029-07-31
- **Final completion:** 2029-07-31
- **Target enrollment:** 125 (ESTIMATED)
- **Last updated:** 2025-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06190158

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06190158, "Subclinical Primary Aldosteronism in Diabetes At-Risk for Kidney Disease". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06190158. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*